statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wockhardt hopes to complete Phase III trials for Zaynich by Q1 of 2025

So far it has supplied the compound to 30 patients for compassionate use with range of life-threatening infections

Wockhardt Ltd Q4 results: Net loss narrows to Rs 169 crore; board approves raising of funds

Wockhardt Ltd also announced that it has re-appointed Dr. Habil Khorakiwala as an Executive Chairman for a further term of five years with effect from 1 March, 2025 to 28th February, 2030.

Wockhardt's R&amp;D prowess attracts marquee investors Madhusudan Kela, Prashant Jain

Wockhardt has two molecules — Nafithromycin (WCK 4873) for treating pneumonia and WCK 5222 for urinary tract infection, in development phases, with launched lined up for FY25 and FY26

Wockhardt stock locked in 5% upper circuit after Prashant Jain, Madhusudan Kela and others invest in QIP

Other prominent names like ICICI Prudential, Mirae Asset Management, Tata Indian Opportunities Fund, Invesco India Smallcap Fund, Gagandeep Credit Capital and Subhkam Ventures were also issued shares in Wockhardt's QIP.

Wockhardt gets nod to raise funds through QIP, sets floor price at Rs 544.02

Sources familiar with the matter told CNBC-TV18 that the total issue size is anticipated to be Rs 570 crore, comprising an issue size of Rs 350 crore and a greenshoe option worth Rs 220 crore.

Wockhardt has more antibiotics in the pipeline: Dr Habil Khorakiwala

Wockhardt could be more of a research company in five years than what it is today.

Wockhardt Ltd. engages in the pharmaceutical business. Its products include formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients. The company was founded by Habil Fakhruddin Khorakiwala in 1967 and is headquartered in Mumbai, India.

Volume	142,239.00
52-Wk High	995.00
52-Wk Low	213.25

WOCKPHARMA.NSE Wockhardt Ltd.

About

Feed

News

Sentiment

Fundamentals